article · Sultan Qaboos University medical journal
We aimed to compare efficacy of vaginal gel preparations versus placebo in postmenopausal women with sexual dysfunction syndrome. We searched electronic databases from inception to January 2023. We included trials reporting Female Sexual Function Index (FSFI) which compared hormonal (estrogen, oxytocin) and/or non-hormonal (chamomile, fennel) interventions versus placebo. We used Cochrane Risk of Bias assessment tool I to evaluate studies quality. Eight trials (N=672 participants) were included. Total FSFI endpoint score was higher in the vaginal gel preparations group (MD: 6.67; 95% CI: [3.79, 9.55]; p Keywords: menopause, psychological sexual dysfunction, estrogen, Chamomile, Meta-analysis
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.18295/squmj.6.2024.040
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
